53 results found
Searchresult 1 - 10 of 53. You filter by “Hospital care”.
-
ACM’s response to the health insurers’ agreement on the distribution of the costs of the COVID-19 crisis for 2020
For 2020, Dutch health insurers are allowed to distribute the costs of the effects of the coronavirus (COVID-19) crisis among themselves. Without such distribution, the continuity of health care provision could be at risk.
-
Dutch health insurers may distribute the additional costs of effects of the coronavirus crisis among each other
This year, Dutch health insurers may distribute the additional costs of the effects of the coronavirus (COVID-19) crisis among themselves. Without such distribution among themselves, the continuity of health care provision could be at risk.
-
ACM closes investigation into drug manufacturer AbbVie, competitors get more room now
Drug manufacturer AbbVie will not force hospitals to purchase exclusively or to a large extent from AbbVie through discount schemes. ACM has closed its investigation into AbbVie and anti-rheumatic drug Humira.
-
ACM studies: the insured’s diversity of wishes affects the negotiation balance between health insurers and hospitals
Health insurers must constantly find the right balance between the various wishes of insured. That affects their position in negotiations with hospitals.
-
ACM: room for collaboration involving the distribution of essential drugs for COVID-19 patients
Hospitals, hospital pharmacies, and pharmaceutical wholesalers are allowed to collaborate closely with each other during the current coronavirus (COVID-19) outbreak in order to prevent or reduce any shortages of essential drugs.
-
Room for collaborations as part of ‘the Right Care in the Right Place’
Many forms of collaborations are allowed. However, collaborations can also go too far. That is why ACM has provided more clarity in its ‘Policy Rule on the Right Care in the Right Place’.
-
ACM Policy Rule on arrangements as part of the movement called ‘The right care in the right place’ (JZOJP)
In this policy rule, ACM explains that it will not impose any fines if collaborations as part of the initiative called ‘the Right Care in the Right Place’ (in Dutch: De Juiste Zorg op de Juiste Plek) meet five criteria.
-
Health insurers and hospitals leave full potential of collective procurement of prescription drugs untapped
Hospitals and health insurers are not yet taking full advantage of the potential benefits that their collaborations in drug procurement are able to offer, according to the evaluation of the ‘Guidelines on collective procurement of prescription drugs’.